{"id":11381,"date":"2011-10-25T00:00:00","date_gmt":"2011-10-24T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2011\/10\/25\/un-ensayo-multicentrico-permitira-comercializar-un-test-genetico-para-el-cancer-de-endometrio\/"},"modified":"2020-05-26T09:43:46","modified_gmt":"2020-05-26T07:43:46","slug":"un-ensayo-multicentrico-permitira-comercializar-un-test-genetico-para-el-cancer-de-endometrio","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2011\/10\/un-ensayo-multicentrico-permitira-comercializar-un-test-genetico-para-el-cancer-de-endometrio\/","title":{"rendered":"Un ensayo multic\u00e9ntrico permitir\u00e1 comercializar un test gen\u00e9tico para el c\u00e1ncer de endometrio"},"content":{"rendered":"
Un ensayo multic\u00e9ntrico de la red de hospitales Red Espa\u00f1ola de Investigaci\u00f3n Traslacional en Ginecolog\u00eda Oncol\u00f3gica (REDITOG), que coordina el investigador de l\u2019IDIBELL y jefe del Servicio de Ginecolog\u00eda del Hospital Universitario de Bellvitge<\/span><\/a>, Jordi Ponce, ha validado la utilizaci\u00f3n de un test gen\u00e9tico para la detecci\u00f3n precoz del c\u00e1ncer de endometrio. El Hospital Universitario de Bellvitge y el IDIBELL han coordinado el ensayo cl\u00ednico que ha incluido m\u00e1s de 500 pacientes<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,253,281],"tags":[],"class_list":["post-11381","post","type-post","status-publish","format-standard","hentry","category-area-cancer","category-cancer-ginecologico","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 12:53:46","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=11381"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11381\/revisions"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=11381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=11381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=11381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
El estudio, que ha incluido m\u00e1s de 500 pacientes, ha sido coordinado por el mismo Ponce y por Antonio Gil, del Hospital Universitario del Vall d\u2019Hebr\u00f3n<\/span><\/a>.
Seg\u00fan los resultados, que se presentaron en el XVII Congreso de la Sociedad Europea de Ginecolog\u00eda Oncol\u00f3gica<\/span><\/a> (ESGO), celebrado del 11 al 14 de septiembre en Mil\u00e1n, esta prueba permite descartar la existencia del tumor en un 97 % de los casos.
Si el test se combina con el examen citol\u00f3gico convencional, la fiabilidad aumenta al 99%, con una especificidad del 97 % y una sensibilidad del 92 %.
M\u00e9s informaci\u00f3: www.ehub.cat<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"